Organic Acid Screen – Quantitative – Urine

The Organic Acid Screen – Quantitative – Urine is a specialised biochemical investigation that measures organic acids and related metabolites excreted in urine. Organic acids are produced naturally when the body processes carbohydrates, fats, amino acids and other nutrients. Most of these substances are normally present in small and predictable quantities. When a metabolic pathway is disrupted, certain organic acids may accumulate and produce a recognisable biochemical pattern.

This test is primarily used to investigate suspected inherited metabolic disorders, including organic acidemias and abnormalities involving amino-acid metabolism, fatty-acid oxidation or cellular energy production. It may also provide useful information in patients with unexplained metabolic acidosis, recurrent vomiting, developmental delay, lethargy, seizures, low blood glucose, abnormal muscle tone or episodic illness. The result must always be interpreted together with the patient's symptoms, medical history and other laboratory investigations.

What Does the Quantitative Urine Organic Acid Screen Measure?

The test evaluates a broad range of organic acids and intermediate metabolites in a urine sample. Depending on the analytical method and laboratory protocol, the report may include numerous compounds associated with amino-acid breakdown, carbohydrate utilisation, fatty-acid metabolism, ketone metabolism, mitochondrial function and cellular energy production.

Gas chromatography–mass spectrometry, commonly called GC-MS, is frequently used to separate, identify and measure these compounds. Many results are reported relative to urine creatinine because the concentration of urine changes according to hydration and kidney function. A quantitative report provides measured concentrations for reportable metabolites, but the overall biochemical pattern is usually more important than one isolated value.

Metabolic Conditions That May Produce Abnormal Results

Urinary organic acid analysis may provide biochemical evidence that supports the investigation of several inherited metabolic conditions. Examples include:

• Methylmalonic acidemia and disorders involving vitamin B12 processing.
• Propionic acidemia and isovaleric acidemia.
• Glutaric acidemia type I and selected related disorders.
• Multiple carboxylase deficiency and biotin-related metabolic abnormalities.
• Beta-ketothiolase deficiency and disorders of ketone metabolism.
• Abnormalities involving branched-chain amino-acid metabolism.
• Some fatty-acid oxidation disorders that cause dicarboxylic aciduria.
• Selected mitochondrial and cellular energy-metabolism disorders.
• Certain nutritional deficiencies and secondary metabolic abnormalities.

The test does not identify every metabolic disorder. Some conditions produce intermittent or subtle abnormalities, while others are more effectively detected using plasma amino acids, an acylcarnitine profile, enzyme analysis or genetic testing. The metabolites included in the test can also vary according to the laboratory method.

Why Is This Test Recommended?

A paediatrician, neurologist, endocrinologist, geneticist, metabolic specialist or other healthcare professional may recommend the quantitative urine organic acid screen when symptoms suggest an abnormal metabolic pathway. It is commonly considered for newborns, children or adults experiencing unexplained neurological or metabolic symptoms.

Possible clinical indications include poor feeding, persistent or recurrent vomiting, lethargy, developmental delay, developmental regression, failure to thrive, seizures, abnormal muscle tone, unusual urine or body odour, metabolic acidosis, unexplained ketosis, low blood glucose, elevated lactate, increased ammonia or severe deterioration during infections and fasting.

The test may also be requested after an abnormal newborn screening result, when another biochemical investigation is abnormal, or when a family member has a confirmed inherited metabolic disorder. In patients who already have a diagnosed metabolic condition, urine organic acid testing may sometimes be used to assess treatment response or metabolic control.

Importance of Collecting the Sample During Symptoms

Some metabolic disorders produce their strongest biochemical abnormalities during an acute episode triggered by fever, infection, prolonged fasting, vomiting or another physiological stress. The concentration of abnormal metabolites may decrease after treatment or when the patient becomes clinically stable. Therefore, a urine sample collected during symptoms may be more informative, provided collection does not interfere with urgent medical treatment.

A normal result obtained between episodes cannot completely exclude an intermittent metabolic disorder. The treating doctor may recommend repeat testing during a future symptomatic episode when clinical suspicion remains high.

Emergency medical treatment must never be delayed merely to obtain a urine sample. An infant or child with persistent vomiting, poor feeding, extreme drowsiness, seizures, rapid or deep breathing, reduced consciousness or suspected metabolic crisis requires immediate hospital evaluation.

Sample Requirements for the Test

A random urine specimen is commonly accepted for a quantitative organic acid screen. A first-morning urine sample may sometimes be preferred in a stable outpatient because it is generally more concentrated. However, when a patient is acutely symptomatic, a sample collected during the episode may offer greater diagnostic value.

General Urine Collection Instructions

1. Use the clean or sterile urine container provided or recommended by the laboratory.
2. Collect the required quantity of urine without adding a preservative unless specifically instructed.
3. Avoid contamination with stool, water, tissue paper, disinfectant, creams or talcum powder.
4. For infants, follow the urine collection procedure recommended by the doctor or laboratory.
5. Clearly label the sample with the patient's name, identification details, collection date and collection time.
6. Refrigerate or freeze the specimen according to the laboratory's instructions.
7. Transport the sample promptly under the recommended temperature conditions.

The exact container, minimum sample volume, storage method and transport conditions should be confirmed with Focus Diagnostics before collection. Proper handling is important because delayed processing or inappropriate storage may affect the stability of certain metabolites.

Is Fasting Required?

Routine fasting is generally not required for this test. A patient with a possible metabolic disorder should not be kept fasting solely to prepare for urine collection because prolonged fasting may trigger or worsen metabolic decompensation. Follow the instructions provided by the treating doctor.

Inform the doctor and laboratory about prescribed medicines, antibiotics, nutritional supplements, specialised formulas, recent dietary changes, prolonged fasting, intravenous fluids or parenteral nutrition. These factors may affect the urinary organic acid profile. Do not stop any prescribed treatment unless the doctor specifically advises it.

How Is the Test Performed?

The collected urine is prepared and analysed using a specialised laboratory technique, commonly gas chromatography–mass spectrometry. The analytical system separates the different organic acids and identifies them according to their chemical characteristics and mass spectra. Reportable metabolites are then measured and compared with appropriate reference intervals.

Urine creatinine is often used to help account for differences in urine concentration. The laboratory may report metabolite concentrations as a ratio to creatinine. Reference values are generally age-dependent and method-dependent, which is particularly important when evaluating newborns and young children.

Understanding the Test Results

The report may identify individual metabolites as normal, increased, decreased or present in an unusual pattern. Interpretation involves reviewing the complete metabolic profile rather than diagnosing a disorder from one isolated result. A clinical specialist considers the patient's age, symptoms, diet, medications, renal function, urine concentration, treatment status and condition at the time of collection.

A characteristic group of abnormal metabolites may strongly suggest a particular metabolic pathway disorder. However, confirmatory testing is normally required before establishing a final diagnosis. Mild or non-specific abnormalities may occur due to fever, fasting, ketosis, dietary intake, gut bacterial activity, medication, nutritional deficiency or specimen-handling factors.

A normal result does not exclude every inherited metabolic disorder. Some diseases are intermittent, some produce only small biochemical changes, and others are not reliably detected through urinary organic acid analysis. A dilute sample may also reduce the likelihood of detecting a mild abnormality.

Possible Follow-Up Investigations

Depending on the findings and clinical presentation, the doctor may recommend one or more additional tests, including:

• Plasma amino-acid analysis.
• Blood acylcarnitine profile.
• Serum ammonia and lactate measurements.
• Blood glucose, electrolytes and blood gas analysis.
• Blood or urine ketone testing.
• Vitamin and nutritional assessments.
• Repeat urine organic acid analysis during symptoms.
• Specific enzyme activity testing.
• Molecular genetic testing to confirm an inherited disorder.

A metabolic physician, clinical geneticist or genetic counsellor may be involved when an inherited disorder is suspected. These specialists can explain the diagnosis, available treatment, inheritance pattern, recurrence risk and possible implications for family members.

Benefits of Quantitative Urine Organic Acid Testing

A significant benefit of this investigation is that one urine sample can provide information about several biochemical pathways. When a characteristic pattern is detected, the test can help narrow the differential diagnosis and guide the selection of focused confirmatory investigations. Early recognition of some metabolic disorders may support timely dietary, nutritional or medical intervention.

In selected patients with an established diagnosis, repeated testing may also assist clinicians in evaluating metabolic control, treatment response or changes associated with illness. Monitoring requirements depend on the specific disorder and must be determined by the treating specialist.

Limitations of the Test

The Organic Acid Screen – Quantitative – Urine is not a universal diagnostic test for all metabolic diseases. Results may be affected by the timing of collection, hydration status, age, renal function, diet, medicines, infection, fasting, treatment and sample storage. Non-specific changes may occur even when an inherited metabolic disorder is not present.

Creatinine correction also has limitations, particularly in newborns, individuals with reduced muscle mass and patients with renal impairment. Reference ranges found online should not be used to interpret the report because laboratories may use different instruments, methods, units and age-specific intervals.

Clinical correlation is essential. The report should be reviewed by the requesting doctor, and significant findings may require confirmation through additional biochemical, enzyme or genetic investigations.

Organic Acid Screen at Focus Diagnostics

The Organic Acid Screen – Quantitative – Urine is available under the pathology and bio-chemistry department at a listed price of ₹4,000. Because this is a specialised investigation, patients should confirm the sample container, required urine quantity, storage instructions and expected reporting time before collection.

When visiting the diagnostic centre, bring the doctor's prescription, previous metabolic reports and relevant medical information whenever available. Details about symptoms, diet, medications, supplements and the patient's clinical condition at the time of collection can assist with appropriate interpretation.

When Is Urgent Medical Attention Necessary?

Seek urgent medical care if a newborn, child or adult develops persistent vomiting, severe weakness, poor feeding, breathing changes, seizures, altered consciousness, profound lethargy or signs of metabolic decompensation. Do not wait for the organic acid test report before seeking emergency evaluation.

Important Medical Disclaimer

This information is provided for general education and does not replace professional medical advice, diagnosis or treatment. The quantitative urine organic acid screen cannot independently diagnose or exclude every inherited metabolic disorder. Always discuss the result with the requesting doctor or an appropriate metabolic specialist.